These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33588862)

  • 1. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
    Qin R; Cao L; Ye C; Wang J; Sun Z
    BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of genes related to survival prognosis of cervical squamous cell carcinoma and construction of prognosis prediction model.
    Qin R; Cao L; Ye C; Wang J; Sun Z
    J Obstet Gynaecol Res; 2021 Sep; 47(9):3310-3321. PubMed ID: 34219322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma.
    Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M
    Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
    Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
    Pan XB; Lu Y; Huang JL; Long Y; Yao DS
    Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.
    Lv X; Liu L; Li P; Yuan Y; Peng M; Jin H; Qin D
    Reprod Sci; 2022 Mar; 29(3):800-815. PubMed ID: 35075611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis.
    Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH
    Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
    He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
    BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
    Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
    Front Immunol; 2021; 12():665407. PubMed ID: 34177903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
    BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer.
    Xia Q; Jin H; Zhang X; Yan W; Meng D; Ding B; Cao J; Li D; Wang S
    Int Immunopharmacol; 2020 Nov; 88():106935. PubMed ID: 32889244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma.
    Yang H; Han X; Hao Z
    Front Mol Biosci; 2021; 8():679474. PubMed ID: 34291084
    [No Abstract]   [Full Text] [Related]  

  • 19. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
    Wang K; Li Y; Wang J; Chen R; Li J
    Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.